08 August 2020>: Clinical Research
Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy
Qun Zhang 1CDE , Fangyuan Gao 1CD , Xue Yang 1D , Ying Hu 1D , Yao Liu 1CD , Yixin Hou 1D , Yuxin Li 1D , Bingbing Zhu 2B , Shuaishuai Niu 1BF , Yunyi Huang 3B , Xianbo Wang 1ADG*DOI: 10.12659/MSM.924040
Med Sci Monit 2020; 26:e924040
Supplementary Table 3 Subgroup analysis of patients with other etiologies.
Probiotics cohort all (rebleeding) | Non-probiotics cohort all (rebleeding) | P-value* | |
---|---|---|---|
Other HBV irrelevant (n=109) | 41 (17) | 68 (40) | 0.037 |
Other HBV correlation (n=5) | 2 (1) | 3 (3) | 0.360 |
HBV – hepatitis B virus. * Subgroup analysis of esophagogastric variceal rebleeding in patients from the probiotics and non-probiotics cohorts using Cox regression. |